$BIIB Recent News Internet, biotech could spawn next

New Post Public Reply Private Reply Replies (0) Message Board

Apr 29, 2014 at 9:34 AM

$BIIB Recent News

Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. Today - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - blogs.marketwatch.com
Scouring the moonscape for leading stocks 3:01 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - blogs.marketwatch.com
Herbalife sinks on probe fears; Zoe’s surges on debut 4:36 p.m. April 11, 2014 - Ben Eisen
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap 4:11 p.m. April 7, 2014 - blogs.marketwatch.com
Biotech bargain? 11:43 a.m. April 1, 2014 - The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch 5:21 a.m. March 31, 2014 - Victor Reklaitis
U.S. stocks end week with losses 7:17 p.m. March 28, 2014 - Anora Mahmudova
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:40 p.m. March 24, 2014 - Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
Investors let air out of biotech amid overheating, pricing concerns 1:42 p.m. March 21, 2014 - blogs.marketwatch.com
U.S. stocks rise; S&P 500 positive for the year 4:39 p.m. March 17, 2014 - Anora Mahmudova
Yahoo gains on Alibaba IPO; Plug Power loses momentum 4:17 p.m. March 17, 2014 - Saumya Vaishampayan
Keurig Green Mountain added to S&P 500 index 9:56 a.m. March 15, 2014 - MarketWatch.com

Biogen to Present Plegridy Data from Phase 3 Study at AAN Annual Meeting 6:31 a.m. Today - benzinga.com
If You Want GARP, Look Into Biotech, Not Utilities, But Do The Valuations 11:35 a.m. April 28, 2014 - Seeking Alpha
Why Gilead Sciences (GILD) Stock Is Up Today 11:16 a.m. April 28, 2014 - TheStreet.com
Stock Market News for April 28, 2014 - Market News 10:06 a.m. April 28, 2014 - Zacks.com
Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. April 26, 2014 - TheStreet.com
Amgen Blazed Biotech Trail, Earned 165,233% Reward 5:51 p.m. April 25, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: EBAY, AXP, BIIB 3:59 p.m. April 25, 2014 - TheStreet.com
Spectrum Pharma Candidate Gets Positive Data - Analyst Blog 5:50 p.m. April 24, 2014 - Zacks.com
Gilead, Alexion, Biogen, Or Celgene: 1 Mindboggling Metric Identifies The Best Value! 4:57 p.m. April 24, 2014 - Seeking Alpha
3 Drugs Stocks Dragging The Industry Down 1:03 p.m. April 24, 2014 - TheStreet.com
Stock Market News for April 24, 2014 - Market News 10:06 a.m. April 24, 2014 - Zacks.com
Ambit Biosciences Slumps: AMBI Falls 7.1% in Session - Tale of the Tape 8:49 a.m. April 24, 2014 - Zacks.com
Prothena Corporation plc (PRTA) Worth Watching: Stock Rises 9.5% - Tale of the Tape 8:44 a.m. April 24, 2014 - Zacks.com
Biogen partners with Quintiles to beef up its clinical development processes 8:18 a.m. April 24, 2014 - Seeking Alpha
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 24, 2014 - Zacks.com
Quintiles, Biogen Idec Announce Comprehensive Clinical Development Partnership 7:01 a.m. April 24, 2014 - benzinga.com
After the Apple Split, Five More Bull Market Stock Splits Needed 6:39 a.m. April 24, 2014 - 247WallSt.com
Biogen Idec's CEO Discusses Q1 2014 Earnings Results - Earnings Call Transcript 10:54 p.m. April 23, 2014 - Seeking Alpha
Will Today Be the Day the Dow Finally Does It? 9:11 p.m. April 23, 2014 - InvestorPlace.com
Biogen Q1, Guidance Strong, But Stock Slips 5:46 p.m. April 23, 2014 - Investors Business Daily

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 3:31 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership 8:01 a.m. April 24, 2014 - BusinessWire - BZX
Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII 8:02 a.m. April 21, 2014 - Marketwire
RBCC Bioprinting Partner Expands Brand Awareness Campaign 4:28 a.m. April 16, 2014 - BusinessWire - BZX
Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months 1:00 p.m. April 15, 2014 - PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept 8:00 a.m. April 15, 2014 - PR Newswire - PRF
Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting 7:30 a.m. April 14, 2014 - BusinessWire - BZX
JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes Herbalife Business 12:36 a.m. April 14, 2014 - ACCESSWIRE
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts 9:00 a.m. April 11, 2014 - BusinessWire - BZX
Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer 7:30 a.m. April 10, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A 7:06 a.m. April 10, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 Pediatric Study of Investigational Therapy Eloctate™ (rFVIIIFc) for Hemophilia A 7:00 a.m. April 10, 2014 - BusinessWire - BZX
RBCC and n3D Seek Out Additional Capital 5:00 a.m. April 9, 2014 - BusinessWire - BZX
Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services 8:00 a.m. April 8, 2014 - PR Newswire - PRF
Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution 5:00 a.m. April 3, 2014 - BusinessWire - BZX
Biogen Idec to Report First Quarter 2014 Financial Results on April 23, 2014 4:01 p.m. March 31, 2014 - BusinessWire - BZX
Sobi: US FDA approves Alprolix(TM) 2:05 a.m. March 31, 2014 - GlobeNewswire
Sobi: US FDA approves Alprolix(TM) 2:01 a.m. March 31, 2014 - Thomson Reuters ONE
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart 6:34 p.m. March 28, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

illycaffè's B Corp™ Recertification Reflects Bold Commitment

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Starr Conspiracy Unveils AI Tool for B2B Tech Firms

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Unicycive's Legal Turmoil: Opportunity for Investor Action

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Brands Must Choose: Cost or Value Leadership?

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Dr. David Lifschutz Honored for Psychiatry Innovation

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Microplastics Webinar: Navigating Complex Regulations

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

NSF Backs New Space Projects: Cooling & Drug Delivery

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

New Podcast by Paralyzed Veterans of America Offers Unique Insights

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

CATL Opens Europe's Largest Battery Service Hub

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...